Literatur
- 1
Salerno F, Gerbes A, Gines P. et al .
Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis.
Gut.
2007;
56
1310-1318
- 2
Gines A, Escorsell A, Gines P. et al .
Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis
with ascites.
Gastroenterology.
1993;
105
229-236
- 3
Alessandria C, Ozdogan O, Guevara M. et al .
MELD score and clinical type predict prognosis in hepatorenal syndrome: relevance
to liver transplantation.
Hepatology.
2005;
41
1282-1289
- 4
Arroyo V, Fernandez J, Gines P.
Pathogenesis and treatment of hepatorenal syndrome.
Semin Liver Dis.
2008;
28
81-95
- 5
Terra C, Guevara M, Torre A. et al .
Renal failure in patients with cirrhosis and sepsis unrelated to spontaneous bacterial
peritonitis: value of MELD score.
Gastroenterology.
2005;
129
1944-1953
- 6
Fasolato S, Angeli P, Dallagnese L. et al .
Renal failure and bacterial infections in patients with cirrhosis: epidemiology and
clinical features.
Hepatology.
2007;
45
223-229
- 7
Follo A, Llovet J M, Navasa M. et al .
Renal impairment after spontaneous bacterial peritonitis in cirrhosis: incidence,
clinical course, predictive factors and prognosis.
Hepatology.
1994;
20
1495-1501
- 8
Toledo C, Salmeron J M, Rimola A. et al .
Spontaneous bacterial peritonitis in cirrhosis: predictive factors of infection resolution
and survival in patients treated with cefotaxime.
Hepatology.
1993;
17
251-257
- 9
Garcia-Tsao G, Parikh C R, Viola A.
Acute kidney injury in cirrhosis.
Hepatology.
2008;
48
2064-2077
- 10
Angeli P, Albino G, Carraro P. et al .
Cirrhosis and muscle cramps: evidence of a causal relationship.
Hepatology.
1996;
23
264-273
- 11
Schrier R W, Arroyo V, Bernardi M. et al .
Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal
sodium and water retention in cirrhosis.
Hepatology.
1988;
8
1151-1157
- 12
Ruiz-del-Arbol L, Monescillo A, Arocena C. et al .
Circulatory function and hepatorenal syndrome in cirrhosis.
Hepatology.
2005;
42
439-447
- 13
Ruiz-del-Arbol L, Urman J, Fernandez J. et al .
Systemic, renal, and hepatic hemodynamic derangement in cirrhotic patients with spontaneous
bacterial peritonitis.
Hepatology.
2003;
38
1210-1218
- 14
Wiest R, Groszmann R J.
Nitric oxide and portal hypertension: its role in the regulation of intrahepatic and
splanchnic vascular resistance.
Semin Liver Dis.
1999;
19
411-426
- 15
Gerbes A L, Gulberg V.
[Hepatorenal syndrome].
Dtsch Med Wochenschr.
2003;
128 Suppl 2
S93-S95
- 16
Caregaro L, Menon F, Angeli P. et al .
Limitations of serum creatinine level and creatinine clearance as filtration markers
in cirrhosis.
Arch Intern Med.
1994;
154
201-205
- 17
Ruiz R, Kunitake H, Wilkinson A H. et al .
Long-term analysis of combined liver and kidney transplantation at a single center.
Arch Surg.
2006;
141
735-741; discussion 741 – 732
- 18
Marik P E, Wood K, Starzl T E.
The course of type 1 hepato-renal syndrome post liver transplantation.
Nephrol Dial Transplant.
2006;
21
478-482
- 19
Gines P, Torre A, Terra C, Guevara M.
Review article: pharmacological treatment of hepatorenal syndrome.
Aliment Pharmacol Ther.
2004;
20 Suppl 3
57-62; discussion 63 – 54
- 20
Brensing K A, Textor J, Perz J. et al .
Long term outcome after transjugular intrahepatic portosystemic stent-shunt in non-transplant
cirrhotics with hepatorenal syndrome: a phase II study.
Gut.
2000;
47
288-295
- 21
Alessandria C, Ottobrelli A, Debernardi-Venon W. et al .
Noradrenalin vs terlipressin in patients with hepatorenal syndrome: a prospective,
randomized, unblinded, pilot study.
J Hepatol.
2007;
47
499-505
- 22
Sen S, Davies N A, Mookerjee R P. et al .
Pathophysiological effects of albumin dialysis in acute-on-chronic liver failure:
a randomized controlled study.
Liver Transpl.
2004;
10
1109-1119
- 23
Mitzner S R, Stange J, Klammt S. et al .
Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: results
of a prospective, randomized, controlled clinical trial.
Liver Transpl.
2000;
6
277-286
- 24
Stange J, Ramlow W, Mitzner S. et al .
Dialysis against a recycled albumin solution enables the removal of albumin-bound
toxins.
Artif Organs.
1993;
17
809-813
- 25
Sola-Vera J, Minana J, Ricart E. et al .
Randomized trial comparing albumin and saline in the prevention of paracentesis-induced
circulatory dysfunction in cirrhotic patients with ascites.
Hepatology.
2003;
37
1147-1153
- 26
Gines A, Fernandez-Esparrach G, Monescillo A. et al .
Randomized trial comparing albumin, dextran 70, and polygeline in cirrhotic patients
with ascites treated by paracentesis.
Gastroenterology.
1996;
111
1002-1010
- 27
Sort P, Navasa M, Arroyo V. et al .
Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis
and spontaneous bacterial peritonitis.
N Engl J Med.
1999;
341
403-409
- 28
Fernandez J, Monteagudo J, Bargallo X. et al .
A randomized unblinded pilot study comparing albumin versus hydroxyethyl starch in
spontaneous bacterial peritonitis.
Hepatology.
2005;
42
627-634
- 29
Fernandez J, Navasa M, Planas R. et al .
Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome
and improves survival in cirrhosis.
Gastroenterology.
2007;
133
818-824
PD Dr. Christine Kurschat
Klinik IV für Innere Medizin, Nephrologie und Allgemeine Innere Medizin
Universitätsklinik Köln
Kerpener Str. 62
50937 Köln
Telefon: 0221/478-89032
Fax: 0221/478-89041
eMail: christine.kurschat@uk-koeln.de
